Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China
· Delayed Price · Currency is CNY 168.40
+7.29 (4.52%)
Apr 29, 2026, 3:14 PM CST
SHE:300760 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 8,136 | 11,668 | 11,582 | 9,607 | 8,002 | Upgrade
|
| Depreciation & Amortization | 1,699 | 1,469 | 1,010 | 885.06 | 700.41 | Upgrade
|
| Other Amortization | 47.65 | 34.42 | 29.16 | 26.31 | 16.65 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10.72 | -4.24 | -2.46 | -6.16 | -4.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 16.47 | 1.75 | 274.92 | 0.74 | 0.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | -115.44 | -178.72 | -69.56 | 5.06 | -0.81 | Upgrade
|
| Provision & Write-off of Bad Debts | 195.27 | 298.93 | 244.18 | 36.78 | -5.94 | Upgrade
|
| Other Operating Activities | 771.05 | 388.97 | 33.63 | -145.31 | -103.06 | Upgrade
|
| Change in Accounts Receivable | -345.55 | -347.15 | -680.91 | -1,047 | -153.44 | Upgrade
|
| Change in Inventory | -677.85 | -782.05 | -201.43 | -523.01 | -133.63 | Upgrade
|
| Change in Accounts Payable | 583.91 | 402.21 | -769.19 | 3,094 | 615.09 | Upgrade
|
| Change in Other Net Operating Assets | -177.47 | -78.85 | 253.87 | 382.89 | 5.4 | Upgrade
|
| Operating Cash Flow | 10,145 | 12,432 | 11,062 | 12,141 | 8,999 | Upgrade
|
| Operating Cash Flow Growth | -18.40% | 12.38% | -8.89% | 34.92% | 1.45% | Upgrade
|
| Capital Expenditures | -2,038 | -1,959 | -2,689 | -1,916 | -1,402 | Upgrade
|
| Sale of Property, Plant & Equipment | 38.42 | 30.74 | 21.66 | 73.33 | 21.73 | Upgrade
|
| Cash Acquisitions | - | -5,773 | -870.82 | - | -3,520 | Upgrade
|
| Investment in Securities | 1,348 | 311.61 | 2,689 | -1,558 | - | Upgrade
|
| Other Investing Activities | 142.32 | 7.18 | 156.15 | 180.02 | 88.32 | Upgrade
|
| Investing Cash Flow | -509.4 | -7,383 | -692.93 | -3,220 | -4,812 | Upgrade
|
| Long-Term Debt Issued | 19.71 | 15.14 | - | - | - | Upgrade
|
| Total Debt Issued | 19.71 | 15.14 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -162.08 | -162.94 | -142.46 | -103.35 | -537.94 | Upgrade
|
| Total Debt Repaid | -162.08 | -162.94 | -142.46 | -103.35 | -537.94 | Upgrade
|
| Net Debt Issued (Repaid) | -142.37 | -147.79 | -142.46 | -103.35 | -537.94 | Upgrade
|
| Issuance of Common Stock | - | - | - | 152.43 | - | Upgrade
|
| Repurchase of Common Stock | -148.93 | -5.4 | -6.08 | -999.94 | -999.99 | Upgrade
|
| Common Dividends Paid | -5,615 | -8,743 | -10,670 | -4,233 | -3,039 | Upgrade
|
| Other Financing Activities | -817.77 | 13.98 | 42.47 | -10.54 | -27.71 | Upgrade
|
| Financing Cash Flow | -6,724 | -8,882 | -10,776 | -5,194 | -4,605 | Upgrade
|
| Foreign Exchange Rate Adjustments | -194.71 | 72.19 | 101.37 | 113.82 | -171.45 | Upgrade
|
| Net Cash Flow | 2,717 | -3,761 | -305.22 | 3,841 | -589.78 | Upgrade
|
| Free Cash Flow | 8,107 | 10,473 | 8,373 | 10,226 | 7,596 | Upgrade
|
| Free Cash Flow Growth | -22.59% | 25.07% | -18.11% | 34.62% | -1.19% | Upgrade
|
| Free Cash Flow Margin | 24.36% | 28.52% | 23.97% | 33.67% | 30.06% | Upgrade
|
| Free Cash Flow Per Share | 6.69 | 8.65 | 6.91 | 8.45 | 6.25 | Upgrade
|
| Cash Income Tax Paid | 2,387 | 3,293 | 3,100 | 2,712 | 2,069 | Upgrade
|
| Levered Free Cash Flow | 6,213 | 6,577 | 3,871 | 7,485 | 4,887 | Upgrade
|
| Unlevered Free Cash Flow | 6,228 | 6,590 | 3,879 | 7,492 | 4,893 | Upgrade
|
| Change in Working Capital | -594.54 | -1,246 | -2,040 | 1,731 | 393.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.